navigating administrative law in patent appeals involving...

46
Navigating Administrative Law in Patent Appeals Involving Review Proceedings Identifying and Preserving Administrative Errors in IPR Proceedings; Impact of Recent Court Decisions Today’s faculty features: 1pm Eastern | 12pm Central | 11am Mountain | 10am Pacific The audio portion of the conference may be accessed via the telephone or by using your computer's speakers. Please refer to the instructions emailed to registrants for additional information. If you have any questions, please contact Customer Service at 1-800-926-7926 ext. 10. THURSDAY, JANUARY 12, 2017 Presenting a live 90-minute webinar with interactive Q&A Arti K. Rai, Elvin R. Latty Professor of Law and co-Director at Duke Law Center for Innovation Policy, Duke Law School, Durham, N.C. Kevin B. Laurence, Partner, Renaissance IP Law Group, Alexandria, Va. Jonathan R.K. Stroud, Chief Patent Counsel, Unified Patents, Washington, D.C.

Upload: others

Post on 04-Aug-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Navigating Administrative Law in Patent

Appeals Involving Review Proceedings Identifying and Preserving Administrative Errors in IPR

Proceedings; Impact of Recent Court Decisions

Today’s faculty features:

1pm Eastern | 12pm Central | 11am Mountain | 10am Pacific

The audio portion of the conference may be accessed via the telephone or by using your computer's

speakers. Please refer to the instructions emailed to registrants for additional information. If you

have any questions, please contact Customer Service at 1-800-926-7926 ext. 10.

THURSDAY, JANUARY 12, 2017

Presenting a live 90-minute webinar with interactive Q&A

Arti K. Rai, Elvin R. Latty Professor of Law and co-Director at Duke Law Center for Innovation Policy,

Duke Law School, Durham, N.C.

Kevin B. Laurence, Partner, Renaissance IP Law Group, Alexandria, Va.

Jonathan R.K. Stroud, Chief Patent Counsel, Unified Patents, Washington, D.C.

Page 2: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Tips for Optimal Quality

Sound Quality

If you are listening via your computer speakers, please note that the quality

of your sound will vary depending on the speed and quality of your internet

connection.

If the sound quality is not satisfactory, you may listen via the phone: dial

1-866-819-0113 and enter your PIN when prompted. Otherwise, please

send us a chat or e-mail [email protected] immediately so we can address

the problem.

If you dialed in and have any difficulties during the call, press *0 for assistance.

Viewing Quality

To maximize your screen, press the F11 key on your keyboard. To exit full screen,

press the F11 key again.

FOR LIVE EVENT ONLY

Page 3: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Continuing Education Credits

In order for us to process your continuing education credit, you must confirm your

participation in this webinar by completing and submitting the Attendance

Affirmation/Evaluation after the webinar.

A link to the Attendance Affirmation/Evaluation will be in the thank you email

that you will receive immediately following the program.

For additional information about continuing education, call us at 1-800-926-7926

ext. 35.

FOR LIVE EVENT ONLY

Page 4: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Navigating Administrative Law in Patent Appeals

Arti K. Rai

Elvin R. Latty Professor

Duke Law School

Page 5: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Threshold Issue: Right to Judicial Review of Admin Action? • Administrative Procedure Act, 5 U.S.C. § 701(a)

• Presumed unless: • statute precludes judicial review

• agency action “committed to agency discretion by law”

• “Strong presumption” in favor of judicial review of admin action, even in interpreting statutes purporting to preclude review (Mach Mining LLC v. EEOC, 575 U.S. __ (2015)

• Courts assume that review of constitutional questions not precluded

5

Page 6: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Judicial Review 101 (APA + “common law”)

facts law (and “mixed questions”)

catch-all/“policy”

relatively “formal” proceeding that Congress has authorized agency to undertake (United States v. Mead Corp., 467 U.S. 837 (1984))

(e.g. trial-type adjudication, notice & comment rulemaking)

generally “substantial evidence” (5 U.S.C. § 706(2)(E)

Chevron v. Natural Resources Defense Fund, 467 U.S. 837 (1984)

arbitrary & capricious/hard look

(e.g. Motor Vehicle Mfrs Ass’n v. State Farm Mut. Ins. Co., 463 U.S. 29 (1983))

informal proceeding (e.g. informal adjudication)

generally “arbitrary and capricious” (5 U.S.C. § 706(2)(A))

Skidmore arbitrary and capricious/”hard look”

6

Page 7: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Application to patent system (1)

• 35 U.S.C. § 2(b)(2)(A): “establish regulations . . . . which . . . shall govern the conduct of proceedings in the Office.”

• Merck & Co. v. Kessler, 80 F.3d 1543 (Fed. Cir. 1996) (“non-substantive” rulemaking authority)

• Chevron deference for “procedural” rules

Law (and mixed questions)

Notice and comment rulemaking on procedural questions

Chevron

7

Page 8: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Application to patent system (2)

• Pre-1999: CAFC denies APA applies to judicial review of PTO

• Dickinson v. Zurko, 527 U.S. 150 (1999)

• Supreme Court says APA applies to (direct) CAFC review of PTO fact-finding in ex parte examination

• But doesn’t specify “arbitrary and capricious”

• CAFC decides (probably incorrectly) that standard is “substantial evidence”

Facts

Ex parte examination

Arbitrary and capricious Substantial evidence

8

Page 9: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Admin Law at CAFC, pre-PTAB Facts Law (and mixed questions) Catch-all for all

decision-making (no specific “policy” category)

Relatively “formal” proceeding that agency is authorized to undertake

(only “procedural” rulemaking, no formal adjudications)

substantial evidence Chevron

(“procedural” rules for which notice and comment is used – Section 2(b)(2)(A)) – Merck & Co. v. Kessler (Fed. Cir. 1996); see also Cooper Technologies v. Dudas, 536 F.3d 1330 (Fed. Cir. 2008)

arbitrary & capricious

Informal proceeding – ex parte examination

substantial evidence: In re Gartside, 203 F.3d 1305 (Fed. Cir. 2000) which applies substantial evidence to ex parte examination)

Skidmore (??) (CAFC doesn’t really apply)

arbitrary & capricious

9

Page 10: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

What’s procedural?

• Tafas v. Doll, 559 F.3d 1345 (Fed. Cir. 2009)

• Relies on DC Circuit approach in JEM • Rules are “procedural” if: “do not themselves alter the rights or interests

of the parties, although they may alter the manner in which the parties . . . present themselves”

• Chevron applies

• Problem for continuation limits (“plain language” of statute prohibits limits)

• But no plain language on examination support document (for >25 claims)

10

Page 11: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Agency “Interpretation” of Regulations • Auer v. Robbins, 519 U.S. 452 (1997) (judicial

deference to agency interpretation of its own regulation unless plainly erroneous or inconsistent with regulation)

• Eli Lilly Co. v. Bd. of Regents of the Univ. of Wash., 334 F.3d 1264 (Fed. Cir. 2003) (same)

11

Page 12: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Key AIA proceedings at PTAB

• inter partes review

• CBM review

• post-grant review

12

Page 13: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Important admin + judicial review issues post-PTAB • Broadest reasonable interpretation (BRI)

• Review of decision to institute

• Claim amendments

13

Page 14: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

CAFC on BRI

• In re Cuozzo Speed Technologies (Fed. Cir. 2015) • Primary argument is straight statutory interpretation

PTO’s longstanding use of BRI + Congress presumed to legislate against background use

• Secondary argument • new rulemaking authority;

• procedural rule adopting BRI reasonable under Chevron step 2

14

Page 15: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Supreme Court on BRI (Cuozzo v. Lee) • Statute leaves “gap”

• “No statutory provision unambiguously directs the agency to use one standard or the other.”

• PTO can use rulemaking to fill in ambiguity under Chevron

• Emphasizes broad scope of 316(a)(4) authority to makes rules “establishing and governing inter partes review.”

• AIA rulemaking authority not just “procedural”

• BRI “reasonable”

15

Page 16: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Decision to institute IPR

• 314(d): “The determination by the Director whether to institute an inter partes review under this section shall be final and nonappealable.”

16

Page 17: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Decision to Institute IPR at CAFC • In re Cuozzo again

• “whether PTAB lacked authority to institute IPR for claims 10 and 14 on grounds on unpatentability not identified in the Petition”

• Petition challenged only claim 17

• CAFC (per Dyk, J.): no review of decision to institute, even after final action

• 6-5 denial of reh’g en banc

17

Page 18: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

At Supreme Court

• “Strong presumption” in favor of judicial review of administrative action

• But 314(d) bars this type of “mine run” dispute • “closely tied to the application and interpretation of

statutes related to the PTO’s decision to initiate inter partes review”

• Do not decide effect on constitutional questions or questions that reach beyond “this section”

• “Shenanigans” may be properly reviewable under 35 U.S.C. § 319 (final written decisions) and APA “catch-all” provision

18

Page 19: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Shenanigan?: PTAB definition of CBM • Versata v. SAP, Versata v. Lee

• Method for determining price of a product

• Texas jury: $391 m judgment (affirmed by CAFC; “final”)

• While appeal pending, SAP files first CBM review

• PTAB says CBM; decision to institute unreviewable

19

Page 20: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

CBM definition

• AIA Section 18(d)(1) (uncodified):

• “patent that claims a method or corresponding apparatus for performing data processing or other operations used in the practice, administration, or management of a financial product or service, except that the term does not include patents for technological inventions”

• PTO says any patents claiming activities that are “financial in nature, incidental to a financial activity, or complementary to a financial activity” are CBM

20

Page 21: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Claim amendment practice

• Currently before CAFC in In Re: Aqua Products

• Regulations involving amendment practice • 37 CFR §§ 42.20(c), 42.121(a)(2)

• “Interpretation” of regulations in Idle Free Systems, Inc. v. Bergstrom, Inc., IPR2012-00027 (PTAB June 11, 2013)

• Microsoft v. Proxyconn: • Idle Free’s requirement that patentee “show patentable

distinction of the substitute claims over the prior art of record” not “plainly erroneous or inconsistent with the regulation or governing statutes”

21

Page 22: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Patent Law and

Administrative Law

Page 23: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

CUOZZO V. LEE (SUPREME COURT)

23

The BRI standard ”represents a reasonable exercise of the rulemaking

authority that Congress delegated to the Patent Office. . . [C]onstruing a

patent claim according to its broadest reasonable construction

helps to protect the public. . . . [and] helps ensure precision while

avoiding overly broad claims, . . . thereby helps prevent a patent

from tying up too much knowledge, while helping members of the

public draw useful information from the disclosed invention and

better understand the lawful limits of the claim.”

Displayed principles of administrative deference and interpretation of their own

rules; emphasis on IPR as an administrative proceeding with a strong public

function, not as a trial-like procedure.

Page 24: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

24

In re Aqua Products, 2015-1177 (Fed. Cir. May

25, 2016) — (en banc) (Dec. 9 he’g)

- Q1: Does PTAB have authority to have PO to bear

burden to show patentability of amended claims

before allowing them?

- Q2: Does PTAB have authority to raise its own

patentability challenges in this context?

PTAB APPEALS TO THE FEDERAL CIRCUIT

Page 25: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

25

Wi-Fi One, LLC v. Broadcom Corp., 2015-1944

(Fed. Cir. Sept. 16, 2016); 2-1

“The Supreme Court stated that the prohibition against reviewability applies to ‘questions that are closely tied to the application and interpretation of statutes related to the Patent Office’s decision to initiate inter partes review.’ Section 315 is just such a statute. The time-bar set forth in section 315 addresses who may seek inter partes review, while section 312 governs what form a petition must take. Both statutes govern the decision to initiate inter partes review.” Two-part test for reviewability; works to preserve SAP v. Versata

PTAB APPEALS TO THE FEDERAL CIRCUIT

Page 26: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

26

Medtronic v. Robert Bosch Healthcare Sys., Inc.,

2015-1977, 2015-1986, 2015-1987 (Fed. Cir. Oct.

20, 2016) (on reh’g)

“The Board’s vacatur of its institution decisions and

termination of the proceedings constitute decisions whether

to institute inter partes review and are therefore “final and

nonappealable” under § 314(d). Nothing in Cuozzo is to the

contrary.”

PTAB APPEALS TO THE FEDERAL CIRCUIT

Page 27: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

27

Click-to-Call Techs. v. Oracle Corp, 2015-1243

(Fed. Cir. Nov. 17, 2016) — (two judges call for en

banc review)

Because we are bound by the court’s previous decisions in Achates and Wi-Fi One, I agree with the court’s dismissal of [the patent owner’s] challenge under § 315(b). I write separately, however, to note that I believe the Supreme Court’s language in Cuozzo leaves room for us to question our reasoning in Achates and to suggest that we do so en banc. O’Malley Concurrence Slip op. at 2 (O’Malley, J., concurring).

PTAB APPEALS TO THE FEDERAL CIRCUIT

Page 28: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

28

Wi-Fi One, LLC v. Broadcom Corp., 2015-1944

(Fed. Cir. Sept. 16, 2016) (granting en banc)

Q: Should this court overrule Achates Reference Publishing, Inc. v. Apple Inc., 803 F.3d 652 (Fed. Cir. 2015) and hold that judicial review is available for a patent owner to challenge the PTO's determination that the petitioner satisfied the timeliness requirement of 35 U.S.C. § 315(b) governing the filing of petitions for inter partes review?

PTAB APPEALS TO THE FEDERAL CIRCUIT

Page 29: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

29

Unwired Planet, LLC v. Google Inc., 2015-1812

(Fed. Cir. Nov. 21, 2016) (Reyna, Plager, Hughes)

“As a threshold matter, the Board reviewed whether the [] patent is a CBM patent. See AIA § 18(d); 37 C.F.R. § 42.301.” “Our jurisdiction includes review of whether the ’752 patent is a CBM patent. Versata Dev. Grp., Inc. v. SAP Am., Inc., 793 F.3d 1306, 1323 (Fed. Cir. 2015).” “We review the Board’s statutory interpretation de novo. Belkin Int’l, Inc. v. Kappos, 696 F.3d 1379, 1381 (Fed. Cir. 2012).”

PTAB APPEALS TO THE FEDERAL CIRCUIT

Page 30: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

30

Unwired Planet, LLC v. Google Inc., 2015-1812

(Fed. Cir. Nov. 21, 2016) (seeking en banc)

Q1: Whether the Federal Circuit has appellate jurisdiction to review the PTAB’s decision to institute review of a “covered business method” patent; Q2: whether the Federal Circuit should defer to the PTO’s interpretation of the definition of “covered business method” patent. The PTO (and thus the PTAB) has broad statutory authority to interpret the AIA, and in Cuozzo, the Supreme Court deferred to the PTO on AIA statutory interpretation. Here the panel failed to even mention the relevant administrative law principles and the leading cases—Chevron, Mead, Skidmore, etc.

PTAB APPEALS TO THE FEDERAL CIRCUIT

Page 31: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

THANK YOU

Contact information:

[email protected]

+16509990899

Page 32: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

Please feel free to contact me

DISCLAIMER

These materials are public information and have been prepared solely for educational and entertainment purposes to contribute to the understanding of U.S. intellectual property law. These materials reflect only the personal views of the authors and are not individualized legal advice. It is understood that each case is fact-specific, and that the appropriate solution in any case will vary. Therefore, these materials may or may not be relevant to any particular situation. Thus, neither the authors nor Unified Patents Inc. cannot be bound either philosophically or as representatives of their various present and future clients to the comments expressed in these materials. The presentation of these materials does not establish any form of attorney-client relationship with the authors or Unified Patents Inc.. While every attempt was made to ensure that these materials are accurate, errors or omissions may be contained therein, for which any liability is disclaimed.

Jonathan Stroud (504) 813-2171

[email protected]

LinkedIn, SSRN

1875 Connecticut Ave. NW Floor 10

Washington, D.C., 20003

Page 33: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

33

Navigating Administrative Law in Patent Appeals

Involving Review Proceedings

Kevin Laurence Renaissance IP Law Group LLP

January 12, 2017

Page 34: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

34

Appeals at the Federal Circuit

0

100

200

300

400

500

600

700

2013 2014 2015 2016*

D.Ct.

PTO

Page 35: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

35

Trial Timeline

Owner Discovery

Period

Petitioner Discovery

Period

1 2 3

Owner Discovery

Period

7

Motions to Exclude Evidence, Etc.

(DD4-DD6)

1 mo.

4 5 6

2 mos. 2 mos.

Page 36: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

36

Belden v. Berk-Tek

• 805 F.3d 1064 (Fed. Cir. 2015) • Reply must be strictly responsive to previous paper

(response or opposition) • Patent owner is entitled to notice and fair opportunity to

meet the grounds of rejection • PTO must – timely inform a patent owner of the matters of fact and law

asserted in review proceeding – give all interested parties opportunity for submission and

consideration of facts and arguments – permit a party to submit rebuttal evidence and to conduct such

cross-examination as may be required – 5 U.S.C. 554(b)(3)

Page 37: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

37

Belden v. Berk-Tek No Midstream Changes

• Section 554(b)(3) means that “an agency may not change theories in midstream without giving respondents reasonable notice of the change’’ and ‘‘the opportunity to present argument under the new theory.’’

Page 38: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

38

Belden v. Berk-Tek FC’s suggestions

• Addressed options when dealing with improper new arguments – Ask for permission to file motion to strike

– Ask for permission to file sur-reply

– File motion to exclude reply evidence (to which you must have objected)

– File observations on cross-exam of reply declarant

– Respond at oral argument

Page 39: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

39

SAS Institute, Inc. v. ComplementSoft

• 825 F.3d 1341 (Fed. Cir. 2016)

• Already-interpreted terms given new construction in final written decision

• “What concerns us is not that the Board adopted a construction in its final written decision, as the Board is free to do, but that the Board 'change[d] theories in midstream.’”

Page 40: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

40

SAS Institute, Inc. v. ComplementSoft Claim Construction Surprises

• “SAS focused its argument on the Board’s institution decision claim interpretation, a reasonable approach considering ComplementSoft agreed with this interpretation in its patent owner’s response and never suggested that the Board adopt the construction that eventually materialized in the final written decision.”

• “It is difficult to imagine either party anticipating that already-interpreted terms were actually moving targets, and it is thus unreasonable to expect that they would have briefed or argued, in the alternative, hypothetical constructions not asserted by their opponent.”

Page 41: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

41

Genzyme v. Biomarin New Evidence

• 825 F.3d 1360 (Fed. Cir. 2016)

– Petitioner cited two in vivo studies in petition that were not part of grounds in trial

– Patent owner raised issue of the in vivo studies in its response

– Petitioner addressed the studies in its replies (there were two IPRs)

– Patent owner conceded at oral hearing that the studies could be used for some purposes such as identifying the state of the art

– Patent owner did not file a motion to exclude or ask to file a surreply

• FC: New evidence is to be expected and is acceptable as long as the opposing party has an opportunity to respond. Patent owner was not denied notice of the studies or an opportunity to respond to them.

• FC: Prior art references may be used to show the state of the art regardless of whether the reference was cited in institution decision.

Page 42: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

42

In re Magnum Oil Tools

• 829 F.3d 1364 (Fed. Cir. 2016)

• Board adopted arguments on behalf of petitioners that could have been, but were not, raised by the petitioner in petition

• Petitioner argued that all of the claims are obvious over Ground #1 (A + B + C) and over Ground #2 ( D + B + C) but merely incorporated by reference its arguments for D from its arguments based on A.

• Patent Owner argued in its Preliminary Response that obviousness argument based on Ground #2 was insufficient for failing to specify where each element of the claim is found in D + B + C or how to modify D, B, or C.

• Board instituted based on Ground #2 only.

• FWD – all claims obvious

Page 43: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

43

In re Magnum Oil Tools Unsupported Ground

• PO argued that the Board relied on a new ground of unpatentability regarding the motivation to combine D + B + C

• PO also argued that there was no evidence to support the Board’s finding that a skilled artisan would have a reasonable expectation of success in removing D’s retaining pins and replacing them with B’s shearable threads.

• Board denied PO’s request for rehearing finding that Petitioner had explained adequately why a skilled artisan would have had a reasonable expectation of success and a motivation to combine the teachings of D + B + C

• Petitioner agreed not to participate in appeal after settlement and was permitted to withdraw by FC; PTO intervened

Page 44: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

44

In re Magnum Oil Tools Board’s Role

• FC held that petitioner improperly incorporated by reference its separate arguments concerning obviousness based on A + B + C and that D + B + C cannot be the basis for a finding of obviousness because D fails to disclose key limitations of the claims and a skilled artisan would not combine D with B + C

• The Board is not “free to adopt arguments on behalf of petitioners that could have been, but were not, raised by the petitioner during an IPR. Instead, the Board must base its decision on arguments that were advanced by a party, and to which the opposing party was given a chance to respond.”

• PTO’s authority is not so broad that it allows the PTO to raise, address, and decide unpatentability theories never presented by the petitioner and not supported by record evidence.

Page 45: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

45

In re Nuvasive Board’s Findings in FWD

• FC held that the PTAB’s Final Written Decision did not make adequately explained findings as to why a PHOSITA would have been motivated to combine the prior art references.

• The Board “must make the necessary findings and have an adequate “evidentiary basis for its findings.” Also, the Board must “must examine the relevant data and articulate a satisfactory explanation for its action including a rational connection between the facts found and the choice made.”

• This explanation enables the court to exercise its duty to review the Board’s decisions to assess whether those decisions are “arbitrary, capricious, an abuse of discretion, or . . . unsupported by substantial evidence . . . .” 5 U.S.C. § 706(2)(A)–(E) (2012); see Dickinson v. Zurko, 527 U.S. 150 (1999).

• We “cannot exercise [our] duty of review unless [we] are advised of the considerations underlying the action under review.” SEC v. Chenery Corp., 318 U.S. 80 (1943).

Page 46: Navigating Administrative Law in Patent Appeals Involving ...media.straffordpub.com/.../presentation.pdf · 12/01/2017  · Medtronic v. Robert Bosch Healthcare Sys., Inc., 2015-1977,

46

For more information contact:

Kevin B. Laurence Partner at Renaissance IP Law Group LLP (703) 448-8787 Desk (703) 463-0640 Mobile [email protected]